MLchartDataset catalogue

granisetron transdermal system

Term · Oncology and biomedicine · MLC-T-ONC-014029

A transdermal system containing the selective serotonin (5-HT) receptor antagonist granisetron with antinauseant and antiemetic activities. Upon application of the transdermal system (patch) to the skin and the subsequent sustained release of granisetron into the bloodstream, granisetron selectively binds to and inhibits 5-HT subtype 3 (5-HT3) receptors located peripherally on vagus nerve terminals and centrally in the chemoreceptor trigger zone (CTZ) of the area postrema, which may result in suppression of chemotherapy-induced nausea and vomiting.

Table 1. Record
IdentifierMLC-T-ONC-014029
FieldOncology and biomedicine
Synonymsgranisetron transdermal patch
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014029",
  "term": "granisetron transdermal system",
  "field": "Oncology and biomedicine",
  "definition": "A transdermal system containing the selective serotonin (5-HT) receptor antagonist granisetron with antinauseant and antiemetic activities. Upon application of the transdermal system (patch) to the skin and the subsequent sustained release of granisetron into the bloodstream, granisetron selectively binds to and inhibits 5-HT subtype 3 (5-HT3) receptors located peripherally on vagus nerve terminals and centrally in the chemoreceptor trigger zone (CTZ) of the area postrema, which may result in suppression of chemotherapy-induced nausea and vomiting.",
  "synonyms": [
    "granisetron transdermal patch"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/granisetron-transdermal-system/"
}

Record 8,179 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.